[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![semodough Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::3426014292.png) dough [@semodough](/creator/twitter/semodough) on x 40.2K followers
Created: 2020-08-06 02:00:06 UTC

Baml $ACAD Raising PT XX from XX Nuplazid beats consensus ($110mn vs $103mn)mgmt. raises lower end of guidance ($430mn-$450mn)early 3Q, specialty pharma channel new Rx trends have returned to pre-COVID levels
DRP PDUFA April 3rd significantly expand pimavanserin potential market


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1291192291680542721/c:line.svg)

**Related Topics**
[$450mnearly](/topic/$450mnearly)
[$430mn](/topic/$430mn)
[$103mnmgmt](/topic/$103mnmgmt)
[$110mn](/topic/$110mn)
[$acad](/topic/$acad)

[Post Link](https://x.com/semodough/status/1291192291680542721)